XML 93 R52.htm IDEA: XBRL DOCUMENT v3.20.4
Acquisition of Tetraphase Pharmaceuticals, Inc - Summary of Purchase Price Allocation as of Acquisition Date (Details) - USD ($)
$ in Thousands
Jul. 28, 2020
Dec. 31, 2020
Business Acquisition [Line Items]    
Goodwill   $ 20,123
Tetraphase Pharmaceuticals, Inc.    
Business Acquisition [Line Items]    
Cash $ 42,990  
Fair value of CVRs 2,610  
Total Purchase Price 45,600  
Cash and cash equivalents 8,778  
Accounts receivable 1,187  
Inventory 4,767  
Prepaid expenses and other current assets 1,218  
Property and equipment 58  
Right-of-use lease assets 2,302  
Restricted cash 699  
Identifiable intangible assets 15,520  
Goodwill 20,123  
Accounts payable (1,400)  
Accrued expenses (2,979)  
Lease liabilities, current portion (967)  
Lease liabilities, less current portion (1,420)  
Other noncurrent liabilities $ (2,286)